NCT03935282 2026-04-15
AH-HA
Wake Forest University Health Sciences
Phase NA Completed
Clinical Trials
4,955 trialsNCT04072952 2026-04-15
mBC
Arvinas Inc.
Phase 1/2 Completed
NCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT02311959 2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3 Completed
NCT05609435 2026-04-14
Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer
University of Wisconsin, Madison
Phase NA Completed
NCT02630693 2026-04-13
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT07162051 2026-04-13
A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Completed
NCT02390427 2026-04-09
Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT02595905 2026-04-08
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
National Cancer Institute (NCI)
Phase 2 Completed
NCT04081779 2026-04-08
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
Phase NA Completed
NCT07307911 2026-04-08
Co-Pa-N
Damanhour University
Phase 2 Completed
NCT02129686 2026-04-07
A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Dana-Farber Cancer Institute
Phase NA Completed
NCT05365230 2026-04-07
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Ottawa Hospital Research Institute
Phase 4 Completed
NCT06020573 2026-04-07
Evaluation of Safety and Performance of Intraoperative Detection of Light Signals During Electrosurgical Breast Cancer Resection
Erbe Elektromedizin GmbH
Phase NA Completed
NCT05064085 2026-04-06
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT05394285 2026-04-06
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT05607017 2026-04-06
Losartan in Prevention of Radiation-Induced Heart Failure
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT07510997 2026-04-06
Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery
Rabin Medical Center
Phase NA Completed
NCT06056843 2026-04-03
PUD
International Agency for Research on Cancer
Phase NA Completed
NCT07160738 2026-04-03
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
Pfizer
Phase 1 Completed
NCT04721886 2026-04-02
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04838756 2026-04-02
MASAI
Region Skane
Phase NA Completed
NCT06070155 2026-04-01
Effect of Aerobic Exercises on Trace Elements in Post-menopausal Women After Radiotherapy
Cairo University
Phase NA Completed
NCT04013568 2026-03-31
Exercise Post-Diagnosis of Breast Cancer
University of Hawaii
Phase NA Completed
NCT04354675 2026-03-31
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT04890028 2026-03-31
DOPACER
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT05058196 2026-03-30
CARTE
UNICANCER
Phase NA Completed
NCT07126522 2026-03-30
Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors
Mayo Clinic
Phase NA Completed
NCT07500038 2026-03-30
EBP-MS-BC
Fudan University
Phase NA Completed
NCT00003140 2026-03-27
Letrozole After Tamoxifen in Treating Women With Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00066443 2026-03-27
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Completed
NCT03328026 2026-03-27
Combination Study of SV-BR-1-GM With Retifanlimab
BriaCell Therapeutics Corporation
Phase 1/2 Completed
NCT05376241 2026-03-27
Promoting Informed Choice for Breast Cancer Screening
University of Colorado, Denver
Phase 2 Completed
NCT06305117 2026-03-27
VRtuose1
International Agency for Research on Cancer
Phase NA Completed
NCT06435546 2026-03-27
AdOTAC
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT04998682 2026-03-25
TAD
University of Miami
Phase NA Completed
NCT03440398 2026-03-24
Robotic Nipple-Sparing Mastectomy Vs Conventional Open Technique
European Institute of Oncology
Phase NA Completed
NCT02654119 2026-03-23
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
University of Nebraska
Phase 2 Completed
NCT04539938 2026-03-23
HER2CLIMB-04
Seagen Inc.
Phase 2 Completed
NCT05963997 2026-03-23
SUMIT-ELA
Carrick Therapeutics Limited
Phase 1/2 Completed
NCT06699875 2026-03-23
Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal
Trak Health Solutions S.L.
Phase NA Completed
NCT07487129 2026-03-23
Clinical and P
Beni-Suef University
Phase 4 Completed
NCT03714243 2026-03-20
BBBD
InSightec
Phase NA Completed
NCT05397457 2026-03-20
Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia
Chang Gung Memorial Hospital
Phase NA Completed
NCT03651973 2026-03-19
ESTAUVAL
Center Eugene Marquis
Phase NA Completed
NCT03709446 2026-03-19
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT05402930 2026-03-19
Angiomammography and Neoadjuvant Chemotherapy
CHU de Quebec-Universite Laval
Phase NA Completed
NCT05659563 2026-03-19
EMPRESS
MedSIR
Phase 2 Completed